Determining the potency of neuromuscular blockers: Are traditional methods flawed?

British Journal of Anaesthesia

Volumn 104, Issue 6, 2010, Pages 705-710

  Kopman, A F ^a   Lien, C A ^a   Naguib, M ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Neuromuscular block; Pharmacology, dose response; Potency, drug; Potency, ED50

Indexed keywords

ALFENTANIL; CISATRACURIUM; FENTANYL; MIDAZOLAM; NEUROMUSCULAR BLOCKING AGENT; NITROUS OXIDE; OPIATE; PROPOFOL; RAPACURONIUM BROMIDE; ROCURONIUM; SUXAMETHONIUM;

ADULT; ANESTHESIA INDUCTION; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DOSE CALCULATION; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG POTENCY; ELECTIVE SURGERY; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; NONLINEAR REGRESSION ANALYSIS; PRIORITY JOURNAL; REFERENCE VALUE; SINGLE DRUG DOSE;

EID: 77952474089     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aeq094     Document Type: Article

References (11)

1. Donlon JV, Ali HH, Savarese JJ. A new approach to the study of four nondepolarizing relaxants in man. Anesth Analg 1974;53:934-8
2. Fuchs-Buder T, Claudius C, Skovgaard LT, Eriksson LI, Mirakhur RK, Viby-Mogensen J. Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision. Acta Anaesthesiol Scand 2007;51:789-808
3. Finney DJ. Probit Analysis. A Statistical Treatment of the Sigmoid Curve, 1st Edn. Cambridge: Cambridge University Press, 1947
4. Motulsky H, Christopoulos A. Fitting Models to Biological Data Using Linear and Nonlinear Regression: A Practical Guide to Curve Fitting. New York: Oxford University Press, 2003; pages 16 and 19
5. Naguib M, Samarkandi AH, Amnar A, Al-Zahrani S. Comparative clinical pharmacology of rocuronium, cisatracurium, and their combination. Anesthesiology 1998;89:1116-24
6. Kopman AF, Klewicka MM, Neuman GG. An alternate method for estimating the dose-response relationships of neuromuscular blocking drugs. Anesth Analg 2000;90:1191-7
7. Kopman AF, Klewicka MM, Ghori K, Flores F, Neuman GG. Dose-response and onset/offset characteristics of rapacuronium. Anesthesiology 2000;93:1017-21
8. Donlon JV, Savarese JJ, Ali HH, Teplik RS. Human dose-response curves for neuromuscular blocking drugs: a comparison of two methods of construction and analysis. Anesthesiology 1980;53:161-6
9. Kopman AF. How low can you go? Lowest effective dose of neuromuscular blocking agent for tracheal intubation. Can J Anaesth 2009;56:473-7
10. 2-opioid anesthesia. Anesth Analg 1996;83:823-9
11. Belmont MR, Lien CA, Quessy S, et al. The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Anesthesiology 1995;82:1139-45